GLP-1 Fusionsproteine

Patent europeic · EP1724284 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP1724284
Numer da la dumonda
EP06118975
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
29-11-2001
Publitgà
22-11-2006
Concedì
29-07-2009
Stritgà
29-11-2021
Motiv
Durada maximala cuntanschida
Classas IPC
C07K 14/605 (2006.01)
C07K 14/765 (2006.01)
C12N 15/62 (2006.01)
A61K 38/38 (2006.01)
A61K 38/26 (2006.01)
C07K 19/00 (2006.01)
A61P 3/10 (2006.01)
Prioritad
US 251954 P 07.12.2000
Derivà da
EP01995845
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 29-11-2021

    Durada maximala cuntanschida

    Published in Swissreg on 29.11.2021

  2. 29-07-2009

    Concedì

    Published in Swissreg on 29.07.2009

  3. 29-07-2009

    Represchentant inscrit

    Representative
    E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich

    Published in Swissreg on 29.07.2009

Partidas

Possessur

Eli Lilly & Company

Lilly Corporate Center, Indianapolis, IN 46285, US

Represchentant

E. Blum & Co. AG

E. Blum & Co. AG Patent- und Markenanwälte VSP

Vorderberg 11, 8044 Zürich

Inventur

Glaesner, Wolfgang

Indianapolis, IN 46254, US

Micanovic, Radmila

Indianapolis, IN 46236, US

Tschang, Sheng-Hung Rainbow

Carmel, IN 46033, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.